Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro
Shani Zev, Keren Raz, Renana Schwartz, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 6, pp. 2957-2966
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
Gabriele La Monica, Alessia Bono, Antonino Lauria, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 12500-12534
Open Access | Times Cited: 98
Molecular Glue Discovery: Current and Future Approaches
Jeffrey A. Dewey, Clémence Delalande, Saara‐Anne Azizi, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9278-9296
Open Access | Times Cited: 44
The role and potential of computer-aided drug discovery strategies in the discovery of novel antimicrobials
Samson O. Oselusi, Phumuzile Dube, Adeshina I. Odugbemi, et al.
Computers in Biology and Medicine (2024) Vol. 169, pp. 107927-107927
Open Access | Times Cited: 18
Perspectives on Computational Enzyme Modeling: From Mechanisms to Design and Drug Development
Kwangho Nam, Yihan Shao, Dan Thomas Major, et al.
ACS Omega (2024)
Open Access | Times Cited: 18
CHARMM at 45: Enhancements in Accessibility, Functionality, and Speed
Wonmuk Hwang, Steven L. Austin, Arnaud Blondel, et al.
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 41, pp. 9976-10042
Open Access | Times Cited: 17
Haste makes waste: A critical review of docking‐based virtual screening in drug repurposing for SARS‐CoV‐2 main protease (M‐pro) inhibition
Guillem Macip, Pol Garcia‐Segura, Júlia Mestres‐Truyol, et al.
Medicinal Research Reviews (2021) Vol. 42, Iss. 2, pp. 744-769
Open Access | Times Cited: 67
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Comprehensive Survey of Consensus Docking for High-Throughput Virtual Screening
Clara Blanes‐Mira, Pilar Fernández-Aguado, Jorge de Andrés-López, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 175-175
Open Access | Times Cited: 41
MetaDOCK: A Combinatorial Molecular Docking Approach
Izaz Monir Kamal, Saikat Chakrabarti
ACS Omega (2023) Vol. 8, Iss. 6, pp. 5850-5860
Open Access | Times Cited: 27
Characterization of the non-covalent interaction between the PF-07321332 inhibitor and the SARS-CoV-2 main protease
Marina Macchiagodena, Marco Pagliai, Piero Procacci
Journal of Molecular Graphics and Modelling (2021) Vol. 110, pp. 108042-108042
Open Access | Times Cited: 41
A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet?
Guillem Macip, Pol Garcia‐Segura, Júlia Mestres‐Truyol, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 259-259
Open Access | Times Cited: 41
Computationally driven discovery of SARS-CoV-2 Mproinhibitors: from design to experimental validation
Léa El Khoury, Zhifeng Jing, Alberto Cuzzolin, et al.
Chemical Science (2022) Vol. 13, Iss. 13, pp. 3674-3687
Open Access | Times Cited: 33
Computational evaluation and benchmark study of 342 crystallographic holo-structures of SARS-CoV-2 Mpro enzyme
Hamlet Khachatryan, Mher Matevosyan, Vardan Harutyunyan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Advances, opportunities, and challenges in methods for interrogating the structure activity relationships of natural products
Christine Mae F. Ancajas, Abiodun S. Oyedele, Caitlin M. Butt, et al.
Natural Product Reports (2024) Vol. 41, Iss. 10, pp. 1543-1578
Open Access | Times Cited: 5
CHARMM-GUI EnzyDocker for Protein–Ligand Docking of Multiple Reactive States along a Reaction Coordinate in Enzymes
Donghyuk Suh, Renana Schwartz, Prashant Kumar Gupta, et al.
Journal of Chemical Theory and Computation (2025)
Open Access
The Need for Continuing Blinded Pose- and Activity Prediction Benchmarks
Christian Krämer, John D. Chodera, Kelly L. Damm‐Ganamet, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease Mpro
Davide Bassani, Matteo Pavan, Giovanni Bolcato, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 180-180
Open Access | Times Cited: 23
Deciphering the binding mechanism of inhibitors of the SARS-CoV-2 main protease through multiple replica accelerated molecular dynamics simulations and free energy landscapes
Li Meng, Xinguo Liu, Shaolong Zhang, et al.
Physical Chemistry Chemical Physics (2022) Vol. 24, Iss. 36, pp. 22129-22143
Closed Access | Times Cited: 22
SARS-CoV2 billion-compound docking
David Rogers, Rupesh Agarwal, Josh V. Vermaas, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 14
In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-bot
Yi An, Jiwoong Lim, Marta Glavatskikh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening
Aayush Gupta, Huan‐Xiang Zhou
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4236-4244
Open Access | Times Cited: 28
Computational molecular interaction between SARS-CoV-2 main protease and theaflavin digallate using free energy perturbation and molecular dynamics
Manish Manish, Smriti Mishra, Ayush Anand, et al.
Computers in Biology and Medicine (2022) Vol. 150, pp. 106125-106125
Open Access | Times Cited: 19
Docking and other computing tools in drug design against SARS-CoV-2
А.В. Сулимов, Ivan Ilin, Anna Tashchilova, et al.
SAR and QSAR in environmental research (2024) Vol. 35, Iss. 2, pp. 91-136
Closed Access | Times Cited: 3
Alchemical approach performance in calculating the ligand-binding free energy
Son Tung Ngo, Quynh Mai Thai, Trung Hai Nguyen, et al.
RSC Advances (2024) Vol. 14, Iss. 21, pp. 14875-14885
Open Access | Times Cited: 3
Multitargeted Molecular Docking and Dynamic Simulation Studies of Bioactive Compounds from Rosmarinus officinalis against Alzheimer’s Disease
Fatima Javed Mirza, Saadia Zahid, Sanila Amber, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7241-7241
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top